Histoplasmosis Induction and Consolidation Therapy Factorial Randomized Clinical Trial (Histo-FACT)

NCT07261150 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

664

Enrollment

OTHER

Sponsor class

Conditions

Histoplasmosis

Interventions

DRUG: LAmB B
DRUG: Posaconazole
DRUG: World Health Organization (WHO)-recommended SOC
DRUG: WHO-recommended SOC Itraconazole

Sponsor

University of Minnesota

Collaborators

[object Object]